Anti-Human CD30 Recombinant Antibody(Iratumumab)

Product Information

Catalog Number	YR1162
Product Name	Anti-Human CD30 Recombinant Antibody(Iratumumab)
Molecular Name	Iratumumab
Alias	Anti-CD30 Recombinant Antibody, Research Grade Iratumumab
CAS Number	640735-09-7
Target	CD30[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	IP, IF, FuncS, FCM, Neut, ELISA, ICC
Buffer	PBS, pH7.5
Background	Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease. This drug was developed by Medarex, which was later acquired by Bristol-Myers Squibb.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price